These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Boonyasampant M; Weitz IC; Kay B; Boonchalermvichian C; Liebman HA; Shulman IA Transfusion; 2015 Oct; 55(10):2398-403. PubMed ID: 25989361 [TBL] [Abstract][Full Text] [Related]
10. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction. Roumenina LT; Bartolucci P; Pirenne F Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341 [TBL] [Abstract][Full Text] [Related]
11. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194 [TBL] [Abstract][Full Text] [Related]
12. Transfusion-Transmitted Plasmodium falciparum in a Patient With Sickle Cell Hemoglobinopathy. Valliani S; Agasthi P; Westney G; Foreman M Ann Intern Med; 2018 Sep; 169(6):417-418. PubMed ID: 29801034 [No Abstract] [Full Text] [Related]
13. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab. Lee LE; Beeler BW; Graham BC; Cap AP; Win N; Chen F Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease. Shaulov A; Rund D; Filon D; Nachmias B; Khalili A; Manny N; Zelig O Transfusion; 2023 May; 63(5):1100-1106. PubMed ID: 36866433 [TBL] [Abstract][Full Text] [Related]
15. Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease. Chonat S; Quarmyne MO; Bennett CM; Dean CL; Joiner CH; Fasano RM; Stowell SR Haematologica; 2018 Oct; 103(10):e483-e485. PubMed ID: 29794144 [No Abstract] [Full Text] [Related]